cc march 3 2016, page-3

Erb has promised a decisive business plan.
Finance!!
EU strategy
US strategy
Science
FICP
CEO

I think we need some honesty and colour on the hard stuff, nobodies going to expect a revolutionary device not to have points of contention even problems.
Given results, progress of the EU trial has been disappointing, that needs a better explanation.
Fibrosis needs a company position.

I'm expecting some clarity but still a lot of fuzziness.